| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.45 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.32 | 0.01 |